Qiagen NV QIAGEN ORD SHS | 42.93 / +3.11% |
News
- Singular Genomics Partners with QIAGEN to Enable QIAseq Kits for the G4 Sequencing Platform
02/28/2022 / 13:30 - GlobeNewswire - Mainz Biomed Appoints Oncology Expert Dr. Rainer Metzger to Strategic Advisory Board
02/09/2022 / 09:01 - GlobeNewswire - DAX to be expanded by 10 companies on Monday
09/17/2021 / 16:30 - TeleTrader - Ten new companies to join DAX on September 20
09/03/2021 / 22:35 - TeleTrader - FDA approves QIAGEN rapid COVID testing
08/06/2021 / 21:01 - TeleTrader - Oncocyte Selected as New “Day One” Launch Site for QIAGEN’s Companion Diagnostics Test to Identify Patients for Amgen’s Newly FDA-Approved Drug LUMAKRAS (Sotorasib) For Advanced Stage Lung Cancer
06/01/2021 / 14:00 - GlobeNewswire - Ellume Establishes Flagship U.S. Manufacturing Facility in Maryland
05/10/2021 / 16:00 - GlobeNewswire - Abcam and MEDx extend precision medicine strategic partnership
04/12/2021 / 11:00 - GlobeNewswire - OpGen Announces Planned Leadership Transition at Next Generation Sequencing and Bioinformatics Subsidiary Ares Genetics
12/09/2020 / 13:30 - GlobeNewswire - HTG Molecular Diagnostics Reports Third Quarter 2020 Results
11/10/2020 / 22:01 - GlobeNewswire - Ellume Secures $30M from National Institutes of Health RADx Initiative to Accelerate Development of Rapid COVID-19 Diagnostics
10/06/2020 / 21:30 - GlobeNewswire - Thermo Fisher's acquisition of Qiagen fails
08/13/2020 / 13:48 - TeleTrader - HTG Molecular Diagnostics Reports Second Quarter 2020 Results
08/11/2020 / 22:01 - GlobeNewswire - OpGen Group Company Ares Genetics Demonstrates Feasibility of CLIA-compliant Next Generation Sequencing Workflow for Identification of Bacterial Pathogens and Antibiotic Resistance Markers
08/11/2020 / 13:30 - GlobeNewswire - HTG Molecular Diagnostics Announces New Commercialization and Distribution Agreement for Companion Diagnostics with QIAGEN
08/10/2020 / 22:01 - GlobeNewswire